References
- Sriamornsak P, Limmatvapirat S, Piriyaprasarth S, et al. A new self-emulsifying formulation of mefenamic acid with enhanced drug dissolution. Asian J Pharm Sci 2015;10:121–127
- Kormosh Z, Matviychuk O. Potentiometric determination of mefenamic acid in pharmaceutical formulation by membrane sensor based on ion-pair with basic dye. Chinese Chem Lett 2013;24:315–317
- Abdolmohammad-Zadeh H, Morshedzadeh F, Rahimpour E. Trace analysis of mefenamic acid in human serum and pharmaceutical wastewater samples after pre-concentration with Ni–Al layered double hydroxide nano-particles. J Pharm Anal 2014;4:331–338
- Wishart DS, Knox C, Guo AC, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006;34(Database issue):D668–72 . PMID: 16381955
- Alshehri SM, Park JB, Alsulays BB, et al. Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technology. J Drug Deliv Sci Technol 2015;27:18–27
- Kindermann C, Matthée K, Strohmeyer J, et al. Tailor-made release triggering from hot-melt extruded complexes of basic polyelectrolyte and poorly water-soluble drugs. Eur J Pharm Biopharm 2011;79:372–381
- Crowley MM, Zhang F, Repka MA, et al. Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm 2007;33:909–926
- Morott JT, Pimparade M, Park JB, et al. The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets. J Pharm Sci 2015;104:124–134
- Singhal S, Lohar VK, Arora V. Hot Melt Extrusion Technique. WebmedCentral Pharm. Pharm. Sci. 2011;2:WMC001459
- Schilling SU, Bruce CD, Shah NH, et al. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets. Int J Pharm 2008;361:158–168
- Stanković M, Frijlink HW, Hinrichs WL. Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization. Drug Discov Today 2015;20:812–823
- Saharan V, Kukkar V, Kataria M, et al. Dissolution enhancement of drugs. Part I: technologies and effect of carriers. Int J Health Res 2009;2:107--124
- Sikarra D, Shukla V, Kharia AA, Chatterjee DP. Techniques for solubility enhancement of poorly soluble drugs: an overview. J Med Pharm Allied Sci 2012;1:1–22
- Yang M, He S, Fan Y, et al. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: Preparation, characterization and evaluation in vivo. Int J Pharm 2014;475:97–109
- Dvořáčková K, Doležel P, Mašková E, et al. The effect of acid pH modifiers on the release characteristics of weakly basic drug from hydrophlilic-lipophilic matrices. AAPS PharmSciTech 2013;14:1341–1348
- Tran TT, Tran PH, Choi HG, et al. The roles of acidifiers in solid dispersions and physical mixtures. Int J Pharm 2010;384:60–66
- Siepe S, Herrmann W, Borchert HH, et al. Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study. J Control Release 2006;112:72–78
- Tran PH, Tran TT, Lee SA, et al. Roles of MgO release from polyethylene glycol 6000-based solid dispersions on microenvironmental pH, enhanced dissolution and reduced gastrointestinal damage of telmisartan. Arch Pharm Res 2011;34:747–755
- Tran PH, Tran HT, Lee BJ. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. J Control Release 2008;129:59–65
- Andrews GP, AbuDiak OA, Jones DS. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. J Pharm Sci 2010;99:1322–1335
- Ha NS, Tran TT, Tran PH, et al. Dissolution-enhancing mechanism of alkalizers in poloxamer-based solid dispersions and physical mixtures containing poorly water-soluble valsartan. Chem Pharm Bull (Tokyo) 2011;59:844–850
- Tran TT, Tran PH, Lee BJ. Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug. Eur J Pharm Biopharm 2009;72:83–90
- Patil H, Tiwari RV, Upadhye SB, et al. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process. Int J Pharm 2015;496:33--41
- Food and Drug Administration. Guidance for industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. Rockville, MD: Food and Drug Administration; 2000 . URL: http://www.fda.gov/cder/guidance/3618fnl.htm
- Romero S, Escalera B, Bustamante P. Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures. Int J Pharm 1999;178:193–202
- Alsulays BB, Park JB, Alshehri SM, et al. Influence of molecular weight of carriers and processing parameters on the extrudability, drug release, and stability of fenofibrate formulations processed by hot-melt extrusion. J Drug Deliv Sci Technol 2015;29:189–198
- Oh CM, Heng PW, Chan LW. Influence of hydroxypropyl methylcellulose on metronidazole crystallinity in spray-congealed polyethylene glycol microparticles and its impact with various additives on metronidazole release. AAPS PharmSciTech. 2015;16:1357--1367
- Patil H, Tiwari RV, Repka MA. Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS PharmSciTech 2015. DOI: 10.1208/s12249-015-0360-7
- Minhaz MA, Rahman MM, Ahsan MQ, et al. Enhancement of solubility and dissolution properties of clonazepam by solid dispersions. Int J Pharm Life Sci 2012;3:1510–1518
- Yang D, Kulkarni R, Behme RJ, Kotiyan PN. Effect of the melt granulation technique on the dissolution characteristics of griseofulvin. Int J Pharm 2007;329:72–80
- Mididoddi PK, Repka MA. Characterization of hot-melt extruded drug delivery systems for onychomycosis. Eur J Pharm Biopharm 2007;66:95–105
- Forster A, Hempenstall J, Tucker I, Rades T. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm 2001;226:147–161
- Sarode AL, Sandhu H, Shah N, et al. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation. Eur J Pharm Sci 2013;48:371–384
- Qian F, Huang J, Hussain MA. Drug-polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development. J Pharm Sci 2010;99:2941–2947
- Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 2002;54:107–117
- Fitzpatrick S, McCabe JF, Petts CR, Booth SW. Effect of moisture on polyvinylpyrrolidone in accelerated stability testing. Int J Pharm 2002;246:143–151
- Maddineni S, Battu SK, Morott J, et al. Influence of process and formulation parameters on dissolution and stability characteristics of Kollidon® VA 64 hot-melt extrudates. AAPS PharmSciTech 2015;16:444–454
- Kreye F, Siepmann F, Siepmann J. Drug release mechanisms of compressed lipid implants. Int J Pharm 2011;404:27–35
- Al-Naser QA, Zhou J, Wang H, et al. Synthesis and optical properties of MgO-doped ZnO microtubes using microwave heating. Opt Mater 2015;46:22–27